Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Denison Pharmaceuticals, LLC
FDA Inspection
•Denison Pharmaceuticals, LLC•February 9, 2023

Denison Pharmaceuticals, LLC – FDA Inspection, Feb 9, 2023

Record Details

This FDA Inspection record concerns Denison Pharmaceuticals, LLC, with an inspection on February 9, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Denison Pharmaceuticals, LLC
Inspection Date
February 9, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Daniel L. Zheng (FDA Associated Person)
  • Lori M. Newman (FDA Associated Person)
  • Sean R. Marcsisin (FDA Associated Person)
View Company Profile

ID · 0676d955-5878-4af8-9e48-26114410d8f5

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1196871
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

18
  1. 21 CFR 211.94(b)Protection from external factors
  2. 21 CFR 211.84(d)(1)Component identity verification
  3. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  4. 21 CFR 211.113(a)Procedures for non-sterile drug products
  5. 21 CFR 211.28(b)Habits of good sanitation & health
  6. 21 CFR 211.165(e)Test methods
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.22(d)Procedures not in writing, fully followed
  9. 21 CFR 211.100(a)Absence of Written Procedures
  10. 21 CFR 211.100(a)Absence of Written Procedures

Showing 10 of 18 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Denison Pharmaceuticals, LLC

7
DateClassificationOfficeProject area
August 26, 2025VAINew England District OfficeColors and Cosmetics Technology
July 29, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 25, 2017VAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
April 5, 2016VAICenter for Drug Evaluation and ResearchUnapproved and Misbranded Drugs
March 15, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Denison Pharmaceuticals, LLC
  • FDA Inspection 1273626 - 2025-08-26
  • FDA Inspection 1240591 - 2024-07-29
  • FDA Inspection 1029761 - 2017-10-25
  • FDA Inspection 969790 - 2016-04-05
  • FDA Inspection 823447 - 2013-03-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Denison Pharmaceuticals, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.